D. Olivieri (Parma, Italy), A. Bourdin (Montpellier, France)
Late Breaking Abstract: Inhaled pitrakinra, an IL-4/IL-13 antagonist, reduced exacerbations in patients with eosinophilic asthma
S. E. Wenzel, P. W. Ind, B. A. Otulana, E. R. Bleecker, P. Kuna, Y. P. Yen (Pittsburgh, Berkeley, Winston-Salem, United States Of America; London, United Kingdom; Kopcinskiego, Poland)
|  |
Late Breaking Abstract: Tiotropium improves lung function in patients with severe uncontrolled asthma
H. Kerstjens, M. Gahlemann, R. Sigmund, M. Engel, J. van Noord (Groningen, Heerlen, Netherlands; Biberach an der Riss, Germany)
| |
Uncontrolled asthma at treated patients – Predictor analysis in a pulmonology department
S. Mihaicuta, S. Ursoniu, D. Dimitriu, S. Frent, C. Ardelean, V. Tudorache (Timisoara, Romania)
| |
Angiotensin-converting enzyme inhibitors-induced cough in asthmatic and non-asthmatic subjects
S. Ivanov, J. Minov, Z. Stojanovski (Skopje, Fyrom)
| |
Increased doses of inhaled corticosteroids versus addition of long-acting beta2 agonists for treatment of asthma
B. J. Lee, Y. J. Jeung, J. Y. Lee, J. W. Paeng, S. R. Lee, D. C. Choi (Seoul, Chungju, Republic Of Korea)
| |
Effe of ascorbic acid on airway hyperresponsiveness in bronchial asthma
Y. Hwang (Jinju, Republic Of Korea)
| |
Advances of selenium add-on treatment in severe steroids-dependant bronchial asthma
J. Voicehovska, G. Orlikov, N. Voskresenska, J. Karpovs, L. Umnova, E. Maulins (Riga, Latvia)
| |
Lung sound monitoring in diagnosis of exercise-induced asthma
V. Abrosimov, S. Glotov, E. Kolganova, V. Kuznetsov (Russian Federation)
| |
Ciclesonide once daily (80 mg/d, 160 mg/d) versus fluticasone propionate twice daily (250 mg/d) in the treatment of patients with persistent asthma
I. G. Stoica, M. Archip, M. Babu (Bucharest, Romania)
| |
A general self-management program improves self-efficacy but not short-term adherence with asthma self-management behavior: A randomized controlled trial
C. Steurer-Stey, M. Storch, B. Steffen-Bürgi, J. Steurer, M. Puhan (Zurich, Zürich, Switzerland; Baltimore, United States Of America)
| |
Knowledge and misconceptions about inhalation therapy in pulmology: Patients vs. medical students
L. Nagorni-Obradovic, D. Pesut, D. Vukovic (Belgrade, Republic Of Serbia)
|  |
Does acute bronchodilator test is predictive of inhaled corticosteroid response in COPD/asthma patients?
H. Abtahi, E. Safavi, S. Abdi, S. Seifirad (Islamic Republic Of Iran)
| |
The effect of face to face education about proper use of metered dose inhaler on asthma control
K. Najafizadeh, S. Kord Rostami, F. Ghorbani, H. R. Khoddami (Tehran, Islamic Republic Of Iran)
| |
Role of of symbicort in treatment of bronchial asthma
U. Farkhutdinov, R. Rachmatullina, S. Farkhutdinov, E. Achmadeeva (Ufa, Russian Federation)
| |
Budesonide/formoterol for maintenance and reliever therapy in real-life in Thailand
W. Boonsawat, B. Thinkhamrop (Thailand)
| |
Patient concerns regarding asthma, COPD and regular therapies: Results from a European survey
D. Olivieri, A. Amadasi, A. Bizzi, S. Paciotti, M. R. Partridge (Parma, Italy; London, United Kingdom)
| |
Non-tuberculous infections in patients with anti-TNF treatment
A. Erer, S. Karaosman, B. Ozcelik, G. Okumus, N. Oktay, Z. Gulbaran, Z. Kilicaslan, T. Cagatay (Istanbul, Turkey)
| |
High doses of omalizumab (OMA) in patients with allergic (IgE-mediated) asthma and IgE/body weight combinations outside the initially approved dosing table
O. Kornmann, H. Watz, C. Munzu, S. Koehne-Voss, V. Erpenbeck, G. Kaiser (Frankfurt, Germany; Horsham, United Kingdom; Basel, Switzerland)
| |
Factors that affect the treatment of patients with asthma
Y. Havlucu, L. Ouml]zdemir (Hatay, Turkey)
| |
In vitro testing of an improved collapsible valved holding chamber (CHC) with a pressurized metered-dose inhaler delivered bronchodilator, simulating an adult mechanically ventilated patient
J. Mitchell, M. Nagel, V. Avvakoumova, J. Malpass (London, Canada)
| |